{"altmetric_id":20914418,"counts":{"readers":{"mendeley":0,"citeulike":1,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["DrugInfoAssn"],"posts_count":1}},"selected_quotes":["Daunting but doable: Designing #Clinical Pharmacology trials for patients w\/ #RenalDisease other special pops."],"citation":{"altmetric_jid":"536246132a83ee225b8b458f","authors":["William B. Smith","Harry Alcorn, Jr"],"doi":"10.1177\/2168479017706512","first_seen_on":"2017-06-08T17:45:34+00:00","issns":["2168-4790","2168-4804"],"journal":"Therapeutic Innovation & Regulatory Science","last_mentioned_on":1496943919,"links":["http:\/\/journals.sagepub.com\/doi\/full\/10.1177\/2168479017706512"],"pubdate":"2017-05-01T00:00:00+00:00","publisher":"SAGE PublicationsSage CA: Los Angeles, CA","title":"Special Populations in Clinical Pharmacology Studies","type":"article"},"altmetric_score":{"score":0.5,"score_history":{"1y":0.5,"6m":0.5,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":8336644,"mean":7.0294968595789,"rank":6326358,"this_scored_higher_than_pct":13,"this_scored_higher_than":1128698,"rank_type":"exact","sample_size":8336644,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":241576,"mean":12.503306004346,"rank":170864,"this_scored_higher_than_pct":18,"this_scored_higher_than":44521,"rank_type":"exact","sample_size":241576,"percentile":18},"this_journal":{"total_number_of_other_articles":352,"mean":5.4518404558405,"rank":279,"this_scored_higher_than_pct":5,"this_scored_higher_than":20,"rank_type":"exact","sample_size":352,"percentile":5},"similar_age_this_journal_3m":{"total_number_of_other_articles":10,"mean":1.4055555555556,"rank":6,"this_scored_higher_than_pct":10,"this_scored_higher_than":1,"rank_type":"exact","sample_size":10,"percentile":10}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/DrugInfoAssn\/statuses\/872872179733594112","license":"gnip","citation_ids":[20914418],"posted_on":"2017-06-08T17:45:19+00:00","author":{"name":"DIA","url":"http:\/\/www.DIAglobal.org","image":"https:\/\/pbs.twimg.com\/profile_images\/511538065395814400\/M8tONEvV_normal.png","description":"DIA is your essential partner in catalyzing knowledge creation and sharing to accelerate health care product development. Get started by joining our email list.","id_on_source":"DrugInfoAssn","tweeter_id":"28870127","geo":{"lt":null,"ln":null},"followers":11768},"tweet_id":"872872179733594112"}]}}